RESEARCH PAPER
Tobacco-related Foetal Origin of Adult Diseases Hypothesis - population studies in Poland
1
Department of Health Promotion, Food and Nutrition, Institute of Rural Health, Lublin, Poland
2
Laboratory of Functional Diagnostics, Institute of Rural Health, Lublin, Poland
3
Department of Computer Science and Health Statistics, Institute of Rural Health, Lublin, Poland
4
Chief Sanitary Inspectorate, Warsaw, Poland; Institute of Haematology and Transfusion Medicine, Warsaw, Poland
5
Institute of Haematology and Transfusion Medicine, Warsaw, Poland
Ann Agric Environ Med. 2012;19(1):117–128
KEYWORDS
Barker’s Foetal Origin of Diseases HypothesisepigeneticsIUGR – intrauterine growth retardationpregnancy outcometobaccofoetal smoke exposuretransgenerational epigenetic inheritance
ABSTRACT
Epidemiological studies in Poland show that tobacco smoking by adolescents at reproductive age is still frequently observed. This concerns both boys and girls. The study was based on all-Polish population studies of health behaviours of adolescents aged 14-24 (Youth Behavioural Polish Survey - YBPS) conducted in 2011, and the Pregnancy-related Assessment Monitoring Survey (PrAMS). More than 12% of pregnant women do not discontinue smoking in association with becoming pregnant and expose the foetus to tobacco smoke, despite being aware of the hazardous effect of smoking on the health of the mother and child. Smoking in pregnancy is mainly observed among mothers with a low education level and those aged under 23. According to the Baker's Foetal Origins of Adult Health and Diseases Hypothesis, exposure of the foetus to the components of tobacco smoke results in many perturbations in the form of a lower birth weight, prematurity, worse state of neonates after birth, and higher susceptibility to contacting civilization diseases at the age of adulthood. The results of studies confirm some observations. Polish studies clearly confirmed a lower birth weight of babies delivered by mothers who smoke; however, earlier termination of pregnancy and worse status of neonates after birth were not observed. According to the Baker's hypothesis, a lower birth weight of babies delivered by smoking mothers during the further life cycle exposes the offspring to the risk of contracting civilization diseases. The efforts undertaken by public health authorities should be biased towards education of the population at reproductive age about the hazardous effect of smoking on the health of the foetus and the offspring born. Women at reproductive age should be encouraged to discontinue smoking in association with the planning of pregnancy and in pregnancy.
REFERENCES (151)
1.
Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986; 1: 1077-1081.
2.
Barker DJ. The developmental origins of adult disease. J Amer Coll Nutr. 2004; 23: 588S-595S.
3.
Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, Lukas RJ, Markou A, Marks MJ, McCallum SE, Parameswaran N, Perkins KA, Picciotto MR, Quik M, Rose JE, Rothenfluh A, Schafer WR, Stolerman IP, Tyndale RF, Wehner JM, Zirger JM. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology. 2007; 190: 269-319.
4.
Onuki M, Yokoyama K, Kimura K, Sato H, Nordin RB, Naing L, Morita Y, Sakai T, Kobayashi Y, Araki S. Assessment of urinary cotinine as a marker of nicotine absorption from tobacco leaves: A study on tobacco farmers in Malaysia. J Occup Health. 2003; 45: 140-145.
5.
Sastry BV, Chance MB, Hemontolor ME, Goddijn-Wessel TA. Formation and retention of cotinine during placental transfer of nicotine in human placental cotyledon. Pharmacology. 1998; 57: 104-116.
6.
Dempsey DA, Benowitz NL. Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf. 2001; 24: 277-322.
7.
Frank L, Sosenko IR. Prenatal development of lung antioxidant enzymes in four species. J Pediatr. 1987; 110: 106-110.
8.
Hayashibe H, Asayama K, Dobashi K, Kato K. Prenatal development of antioxidant enzymes in rat lung, kidney, and heart: Marked increase in immunoreactive superoxide dismutases, glutathione peroxidase, and catalase in the kidney. Pediatr Res. 1990; 27: 472-475.
9.
Walther FJ, Wade AB, Warburton D, Forman HJ. Ontogeny of antioxidant enzymes in the fetal lamb lung. Exp Lung Res. 1991; 17: 39-45.
10.
Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol. 1996; 20: 115-126.
11.
Kleinsasser NH, Sassen AW, Semmler MP, Harreus UA, Licht AK, Richter E. The tobacco alkaloid nicotine demonstrates genotoxicity in human tonsillar tissue and lymphocytes. Toxicol Sci. 2005; 86: 309-317.
12.
Guo J, Chu M, Abbeyquaye T, Chen CY. Persistent nicotine treatment potentiates amplification of the dihydrofolate reductase gene in rat lung epithelial cells as a consequence of Ras activation. J Biol Chem. 2005; 280: 30422-30431.
13.
Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994; 266: 1821-1828.
14.
Noakes PS, Thomas R, Lane C, Mori TA, Barden AE, Devadason SG, Prescott SL. Association of maternal smoking with increased infant oxidative stress at 3 months of age. Thorax. 2007; 62: 714-717.
15.
Orhon FS, Ulukol B, Kahya D, Cengiz B, Baskan S, Tezcan S. The influence of maternal smoking on maternal and newborn oxidant and antioxidant status. Eur J Pediatr. 2009; 168: 975-981.
16.
Bruin JE, Petre MA, Raha S, Morrison KM, Gerstein HC, Holloway AC. Fetal and neonatal nicotine exposure in Wistar rats causes progressive pancreatic mitochondrial damage and beta cell dysfunction. PLoS One. 2008; 3: e3371.
17.
Husain K, Scott BR, Reddy SK, Somani SM. Chronic ethanol and nicotine interaction on rat tissue antioxidant defense system. Alcohol. 2001; 25: 89-97.
18.
Horta BL, Victora CG, Menezes AM, Halpern R, Barros FC. Low birthweight, preterm births and intrauterine growth retardation in relation to maternal smoking. Paediatr Perinat Epidemiol. 1997; 11: 140-151.
19.
Andersen KV, Hermann N. Placenta flow reduction in pregnant smokers. Acta Obstet Gynecol Scand. 1984; 63: 707-709.
20.
Lindblad A, Marsal K, Andersson KE. Effect of nicotine on human fetal blood flow. Obstet Gynecol. 1988; 72: 371-382.
21.
Jauniaux E, Burton GJ. The effect of smoking in pregnancy on early placental morphology. Obstet Gynecol. 1992; 79: 645-648.
22.
Burton GJ, Palmer ME, Dalton KJ. Morphometric differences between the placental vasculature of nonsmokers, smokers and ex-smokers. Br J Obstet Gynaecol. 1989; 96: 907-915.
23.
Larsen LG, Clausen HV, Jonsson L. Stereologic examination of placentas from mothers who smoke during pregnancy. Am J Obstet Gynecol. 2002; 186: 531-537.
24.
Genbacev O, Bass KE, Joslin RJ, Fisher SJ. Maternal smoking inhibits early human cytotrophoblast differentiation. Reprod Toxicol. 1995; 9: 245-255.
25.
Genbacev O, McMaster MT, Zdravkovic T, Fisher SJ. Disruption of oxygen-regulated responses underlies pathological changes in the placentas of women who smoke or who are passively exposed to smoke during pregnancy. Reprod Toxicol. 2003; 17: 509-518.
26.
Vik T, Jacobsen G, Vatten L, Bakketeig LS. Pre- and post-natal growth in children of women who smoked in pregnancy. Early Human Development. 1996; 45: 245–255. doi: 10.1016/0378-3782(96)01735-5.
27.
Ellard GA, Johnstone FD, Prescott RJ, Ji-Xian W, Jian-Hua M. Smoking during pregnancy: the dose dependence of birthweight deficits. Br J Obstet Gynaecol. 1996; 103: 806–813.
28.
Ong KK, Ahmed ML, Emmett PM, Preece MA, Dunger DB. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ. 2000; 320: 967–971. doi: 10.1136/bmj.320.7240.967.
29.
Dulloo AG, Jacquet J, Montani JP. Pathways from weight fluctuations to metabolic diseases: focus on maladaptive thermogenesis during catch-up fat. Int J Obes Relat Metab Disord. 2002; 26(Suppl 2): S46-S57. doi: 10.1038/sj.ijo.0802127.
30.
Ross MG, Desai M. Gestational programming: population survival effects of drought and famine during pregnancy. Am J Physiol Regul Integr Comp Physiol. 2005; 288: R25-33.
31.
Montgomery SM, Ekbom A. Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort. BMJ. 2002; 324: 26-27. doi: 10.1136/bmj.324.7328.26.
32.
von Kries R, Toschke AM, Koletzko B, Slikker W., Jr Maternal smoking during pregnancy and childhood obesity. Am J Epidemiol. 2002; 156: 954-961. doi: 10.1093/aje/kwf128.
33.
Dubois L, Girard M. Early determinants of overweight at 4.5 years in a population-based longitudinal study. Int J Obes. (Lond) 2006; 30: 610-617. doi: 10.1038/sj.ijo.0803141.
34.
Power C, Jefferis BJ. Fetal environment and subsequent obesity: a study of maternal smoking. Int J Epidemiol. 2002; 31: 413-419. doi: 10.1093/ije/31.2.413.
35.
Wideroe M, Vik T, Jacobsen G, Bakketeig LS. Does maternal smoking during pregnancy cause childhood overweight? Paediatr Perinat Epidemiol. 2003 ;17: 171-179. doi: 10.1046/j.1365-3016.2003.00481.x.
36.
Toschke AM, Koletzko B, Slikker W, Jr, Hermann M, von Kries R. Childhood obesity is associated with maternal smoking in pregnancy. Eur J Pediatr. 2002; 161: 445–448. doi: 10.1007/s00431-002-0983-z.
37.
Adams AK, Harvey HE, Prince RJ. Association of maternal smoking with overweight at age 3 y in American Indian children. Am J Clin Nutr. 2005; 82: 393-398.
38.
Fox NL, Sexton M, Hebel JR. Prenatal exposure to tobacco: I. Effects on physical growth at age three. Int J Epidemiol. 1990; 19: 66-71. doi: 10.1093/ije/19.1.66.
39.
Toschke AM, Montgomery SM, Pfeiffer U, von Kries R. Early intrauterine exposure to tobacco-inhaled products and obesity. Am J Epidemiol. 2003; 158: 1068-1074. doi: 10.1093/aje/kwg258.
40.
Oken E, Huh SY, Taveras EM, Rich-Edwards JW, Gillman MW. Associations of maternal prenatal smoking with child adiposity and blood pressure. Obes Res. 2005; 13: 2021-2028. doi: 10.1038/oby.2005.248.
41.
Hill SY, Shen S, Locke Wellman J, Rickin E, Lowers L. Offspring from families at high risk for alcohol dependence: increased body mass index in association with prenatal exposure to cigarettes but not alcohol. Psychiatry Res. 2005; 135: 203-216. doi: 10.1016/j.psychres.2005.04.003.
42.
Law CM, Shiell AW. Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature. J Hypertens. 1996; 14: 935-941. doi: 10.1097/00004872-199608000-00002.
43.
Blake KV, Gurrin LC, Evans SF, Beilin LJ, Landau LI, Stanley FJ, Newnham JP. Maternal cigarette smoking during pregnancy, low birth weight and subsequent blood pressure in early childhood. Early Hum Dev. 2000; 57: 137-147. doi: 10.1016/S0378-3782(99)00064-X.
44.
Lawlor DA, Najman JM, Sterne J, Williams GM, Ebrahim S, Smith GD. Associations of Parental, Birth, and Early Life Characteristics With Systolic Blood Pressure at 5 Years of Age: Findings From the Mater-University Study of Pregnancy and Its Outcomes. Circulation. 2004; 110: 2417-2423. doi: 10.1161/01.CIR.0000145165.80130.B5.
45.
Hofhuis W, de Jongste JC, Merkus PJ. Adverse health effects of prenatal and postnatal tobacco smoke exposure on children. Arch Dis Child. 2003; 88: 1086-1090.
46.
Lodrup Carlsen KC, Jaakkola JJ, Nafstad P, Carlsen KH. In utero exposure to cigarette smoking influences lung function at birth. Eur Respir J. 1997; 10: 1774-1779.
47.
Maritz GS, Harding R. Life-long Programming Implications of Exposure to Tobacco Smoking and Nicotine Before and Soon After Birth: Evidence for Altered Lung Development. Int J Environ Res Public Health. 2011; 8 :875-898.
48.
Stocks J, Dezateux C. The effect of parental smoking on lung function and development during infancy. Respirology. 2003; 8: 266-285.
49.
von Mutius E. Environmental factors influencing the development and progression of pediatric asthma. J Allergy Clin Immunol. 2002; 109(suppl 6): S525-32.
50.
Landau LI. Tobacco smoke exposure and tracking of lung function into adult life. Paediatr Respir Rev. 2008; 9: 39-43.
51.
Gilliland FD, Berhane K, McConnell R, Gauderman WJ, Vora H, Rappaport EB, Avol E, Peters JM. Maternal smoking during pregnancy, environmental tobacco smoke exposure and childhood lung function. Thorax. 2000; 55: 271-276.
52.
Goksor E, Amark M, Alm B, Gustafsson PM, Wennergren G. The impact of pre- and post-natal smoke exposure on future asthma and bronchial hyper-responsiveness. Acta Paediatr. 2007; 96: 1030-1035.
53.
Henderson AJ, Newson RB, Rose-Zerilli M, Ring SM, Holloway JW, Shaheen SO. Maternal Nrf2 and gluthathione-S-transferase polymorphisms do not modify associations of prenatal tobacco smoke exposure with asthma and lung function in school-aged children. Thorax. 2010; 65: 897-902.
54.
Upton MN, Smith GD, McConnachie A, Hart CL, Watt GC. Maternal and personal cigarette smoking synergize to increase airflow limitation in adults. Am J Respir Crit Care Med. 2004; 169: 479-487.
55.
Anderson HR, Cook DG. Passive smoking and sudden infant death syndrome: review of the epidemiological evidence. Thorax. 1997; 52: 1003-9.
56.
Strachan DP, Cook DG. Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax. 1997; 52: 905-14.
57.
Gurkan F, Kiral A, Dagli E, et al. The effect of passive smoking on the development of respiratory syncytial virus bronchiolitis. Eur J Epidemiol. 2000; 16: 465-8.
58.
Yusuf HR, Rochat RW, Baughman WS, et al. Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996. Am J Public Health. 1999; 89: 712-17.
59.
Kriz P, Bobak M, Kriz B. Parental smoking, socioeconomic factors, and risk of invasive meningococcal disease in children: a population based case-control study. Arch Dis Child. 2000; 83: 117-21.
60.
Hackshaw A, Rodeck C,Boniface S, Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed casus and 11.7 million controls. Human Reproduction Update, Vol.0, No.0 pp. 1-16, 2010 doi:10.1093/humupd/dmr022.
61.
Suter M, Ma J, Harris AS, Patterson L, Brown KA, Shope C, Showalter L, Abramovici A, & Aagaard-Tillery KM. Maternal tobacco use modestly alters correlated epigenome-wide placental DNA methylation and gene expression. Epigenetics. 2011; 6(11): 1284-1294.
62.
Suter M, Abramovici A, Aagaard-Tillery K. Genetic and epigenetic influences associated with intrauterine growth restriction due to in utero tobacco exposure. Pediatr Endocrinol Rev. 2010; 8: 94-102.
63.
Aagaard-Tillery K, Suter M, Harris A, Abramovici AJC. Epigenetics and reproduction and the developmental origins of health and disease. Animal Reproduction. 2010; 7: 103-16.
64.
Suter M, Bocock P, Showalter L, Hu M, Shope C, McKnight R, et al. Epigenomics: maternal high-fat diet exposure in utero disrupts peripheral circadian gene expression in nonhuman primates. FASEB J. 2011; 25: 714-26.
65.
Suter MA, Aagaard-Tillery KM. Environmental influ ences on epigenetic profiles. Semin Reprod Med. 2009; 27: 380-90.
66.
Sood R, Zehnder JL, Druzin ML, Brown PO. Gene expression patterns in human placenta. Proc Natl Acad Sci USA. 2006; 103: 5478-83.
67.
Suter M Ma J, Harris A, Patterson L, Brown K,A, Shope C, Showalter L, Abramovici A, Aagaard-Tillery KM. Maternal tobacco use modestly alters correlated epigenome-wide placental DNA methylation and gene expression. Epigenetics. 2011; 6(11): 1284-1294.
68.
Rasmussen TP. Embryonic stem cell differentiation: a chromatin perspective. Reprod Biol Endocrinol. 2003; 1: 100.
69.
Larsen WJ, Sherman LS, Potter SS, Scott WS. Human Embryology. Churchill Livingstone Philadelphia, PA: 2001.
70.
Guerrero-Preston R. Global epigenetic screening technologies: a novel tool to address cancer health disparities in high-risk population groups. P R Health Sci J. 2008; 27: 350-6.
71.
Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science. 2001; 293: 1089-1093.
72.
Breton CV, Hyang-Min Byun,Wenten M, Fei Pan,,Yang, A, Gilliland FD,Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation AJRCCM Articles in Press. Published on June 4, 2009 as doi:10.1164/rccm.200901-0135OC http://171.66.122.149/content/....
73.
Herceg Z. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis. 2007; 22: 91-103.
74.
Jensen TJ, Novak P, Wnek SM, Gandolfi AJ, Futscher BW. Arsenicals produce stable progressive changes in DNA methylation patterns that are linked to malignant transformation of immortalized urothelial cells. Toxicol Appl Pharmacol. 2009; 241: 2 21-9.
75.
Chen H, Li S, Liu J, Diwan BA, Barrett JC, Waalkes MP. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis. 2004; 25: 1779-86.
76.
Vahter M. Effects of arsenic on maternal and fetal health. Annu Rev Nutr. 2009; 29: 381-99.
77.
Huang D, Zhang Y, Qi Y, Chen C, Ji W. Global DNA hypomethylation, rather than reactive oxygen species (ROS), a potential facilitator of cadmium-stimulated K562 cell proliferation. Toxicol Lett. 2008; 179: 43-7.
78.
Ronco AM, Urrutia M, Montenegro M, Llanos MN. Cadmium exposure during pregnancy reduces birth weight and increases maternal and foetal glucocorticoids. Toxicol Lett. 2009; 188: 186-91.
79.
Pavanello S, Bollati V, Pesatori AC, Kapka L, Bolognesi C, Bertazzi PA, et al. Global and gene-specific promoter methylation changes are related to anti-B[a]PDEDNA adduct levels and influence micronuclei levels in polycyclic aromatic hydrocarbon-exposed individuals. Int J Cancer. 2009; 125: 1692-7.
80.
Breton CV, Byun HM, Wenten M, Pan F, Yang A, Gilliland FD. Prenatal Tobacco Smoke Exposure Affects Global and Gene-Specific DNA Methylation. Am J Respir Crit Care Med. 2009; 180: 462-467.
81.
Smith IM, Mydlarz WK, Mithani SK, Califano JA. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int J Cancer. 2007; 121: 1724-8.
82.
Terry MB, Ferris JS, Pilsner R, Flom JD, Tehranifar P, Santella RM, et al. Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiol Biomarkers Prev. 2008; 17: 2306-10.
83.
Guerrero-Preston R, Goldman LR, Brebi-Mieville P, Ili-Gangas C, Lebron C, Witter FR, Apelberg BJ, Hernández-Roystacher M, Jaffe A, Halden RU, Sidransky D.Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds. Epigenetics. 2010 Aug 16; 5(6): 539-46. Epub 2010 Aug 16.
84.
Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet. 2007; 8: 253-62.
85.
Curley JP, Mashoodh R. Parent-of-origin and trans-generational germline influences on behavioral development: the interacting roles of mothers, fathers, and grandparents. Dev Psychobiol. 2010; 52: 312-30.
86.
Skinner MK, Guerrero-Bosagna C. Environmental signals and transgenerational epigenetics. Epigenomics. 2009; 1: 111-7.
87.
Perera F, Herbstman J. Prenatal environmental exposures, epigenetics, and disease. Reprod Toxicol. 2011; 31(3): 363-73.
88.
Anway MD, Leathers C, Skinner MK. Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease. Endocrinology 2006; 147: 5515-23.
90.
Zatoński WA, the HEM project team. Epidemiological analysis of health situation development in Europe and its causes until 1990 Ann Agric Environ Med. 2011; 18(2):194-202.
91.
Zatoński WA, Mańczuk M, Kielce PONS team. POlish-Norwegian Study (PONS): research on chronic non-communicable diseases in European high risk countries – study design. Ann Agric Environ Med. 2011; 18(2): 203-206.
92.
Zatońska K, Ilow R, Regulska-Ilow B, Różańska D, Szuba A, Wołyniec M, Einhorn J, Vatten L, Asvold BO, Mańczuk M, Zatoński WA. Prevalence of diabetes mellitus and IFG in the prospective cohort ‘PONS’ study – baseline assessment Ann Agric Environ Med. 2011; 18(2): 265-269.
93.
Zatońska K, Regulska-Ilow B, Janik-Koncewicz K, Ilow R, Różańska D, Szuba A, Einhorn J, Vatten L, Xiao-Mei M, Janszky I, Paprzycki P, Sulkowska U, Goździewska M, Mańczuk M, Zatoński WA. Prevalence of obesity – baseline assessment in the prospective cohort ‘PONS’ study Ann Agric Environ Med. 2011; 18(2): 246-250.
94.
Janszky I, Vatten L, Romundstad P, Laugsand LE, Håkon Bjørngård J, Mańczuk M, Zatoński WA. Metabolic syndrome in Poland – the PONS Study Ann Agric Environ Med 2011; 18(2): 270-272.
95.
Szuba A, Martynowicz H, Zatońska K, Ilow R, Regulska-Ilow B, Różańska D, Wołyniec M, Einhorn J, Vatten L, Asvold BO, Mańczuk M, Zatoński WA. Prevalence of hypertension in a sample of Polish population – baseline assessment from the prospective cohort ‘PONS’ study Ann Agric Environ Med. 2011; 18(2): 260-264.
96.
Romundstad P, Janszky I, Vatten L, Håkon Bjørngård J, Langhammer A, Mańczuk M, Zatoński WA. Cancer risk factors in Poland: the PONS Study Ann Agric Environ Med. 2011; 18(2): 251-254.
97.
Kaneita Y, Tomofumi S, Takemura S, Suzuki K, Yokoyama E, Miyake T, Harano S, Ibuka E, Kaneko A, Tsutsui T, Ohida T. Prevalence of smoking and associated factors among pregnant women in Japan. Prev Med. 2007; 45: 15-20.
98.
Mohsin M, Bauman AE. Socio-demographic factors associated with smoking and smoking cessation among 426,344 pregnant women in New South Wales, Australia. BMC Public Health. 2005; 5: 138.
99.
Jimenez Ruiz CA. Nicotine replacement therapy during pregnancy. Arch Bronconeumol. 2006; 42: 404-409.
101.
Smoking during pregnancy – United States, 1990-2002. MMWR Surveill Summ. 2004; 53: 911-15.
102.
Ebrahim SH, Floyd RL, Merritt RK, Decoufle P, Holtzman D. Trends in pregnancy-related smoking rates in the United States, 1987-1996. JAMA. 2002; 283: 361-6.
103.
Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2005. Natl Vital Stat Rep. 2007; 56(6).
104.
CDC. Smoking prevalence among women of reproductive age – United States, 2006. MMWR 2008; 57: 849-52.
105.
Perreira KM, Cortes KE. Race/ethnicity and nativity differences in alcohol and tobacco use during pregnancy. Am J Public Health. 2006; 96: 1629-36.
106.
Yu SM, Park CH, Schwalberg RH. Factors associated with smoking cessation among US pregnant women. Matern Child Health J. 2002; 6: 89-97.
107.
Kahn RS, Certain L, Whitaker RC. A reexamination of smoking before, during and after pregnancy. Am J Public Health. 2002; 92: 1801-8.
108.
US Surgeon General. U.S. Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking–Attributable Disease. A Report of the Surgeon General. Public Health Service. Office of the Surgeon General 2010.
109.
Tong VT, Jones JR, Dietz PM, D’Angelo D, Bombard JM. Trends in smoking before, during, and after pregnancy – Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 sites, 2000–2005. Morbidity and mortality weekly report. Centers for Disease Control and Prevention, 2009; 29: SS-4.
110.
Williams L, Morrow B, Shulman H, Stephens R, D’Angelo D, Fowler CI. PRAMS 2002 Surveillance Report Atlanta, GA: Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 2006. http://www.cdc.gov/ PRAMS/Reports.htm.
111.
Centers for Disease Control and Prevention. Trends in Smoking Before, During, and After Pregnancy – Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 Sites, 2000-2005. Surveillance Summaries, May 29, 2009; 58: SS-4. MMWR.
112.
U.S. Department of Health and Human Services. Health, United States, with chart books and trends in the health of Americans (DHHS Publication No. 1232). U.S Department of Health and Human Services Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, MD; 2002.
113.
Sardu C, Mereu A, Pitzalis G, Minerba L, Contu P. Smoking trends in Italy from 1950-2000. J Epidemiol Commmunity Health. 2006; 60(9): 799-803.
114.
National Board of Health Denmark. Survey of smoking habits in Denmark 2002. National Board of Health Denmark, Copenhagen; 2002.
115.
Statistics Sweden.Swedish survey of living conditions. Statistics Sweden, Stockholm; 2002.
116.
Einarson A, Riordan S. Smoking in pregnancy and lactation: a review of risks and cessation strategies. Eur J Clin Pharmacol. 2009; 65: 325-330 doi 10.1007/s00228-008-0609-0.
117.
Jensen KE, Jensen A, Nohr B, Kruger-Kjaer S. Do pregnant women still smoke? A study of smoking patterns among 261,029 primiparous women in Denmark 1997-2005. Acta Obstem Gynecol. 2008; 87: 760-767.
118.
Jaakkola N, Jaakkola MS, Gissler M, Jaakkola JJ. Smoking during pregnancy in Finland: determinants and trends, 1987–1997. Am J Public Health. 2001; 91(2): 284-286.
119.
Baska T, Sovinova H, Nemeth A, Przewozniak K, Warren C, Kavcova E. Czech Republic, Hungary, Poland and Slovakia GYTS Collaborative Group. Findings from the Global Youth Tobacco Survey (GYTS) in Czech Republic, Hungary, Poland and Slovakia – smoking initiation, prevalence of tobacco use and cessation. Soz Praventiv Med. 2006; 51: 110-116.
120.
Perlman F, Bobak M, Gilmore A, McKee M. Trends in the prevalence of smoking in Russia during the transition to a market economy. Tob Control. 2007; 16(5): 299-305.
121.
Przewoźniak K, Łobaszewski J, Cedzyńska M, Wojtyła A, Paprzycki P, Mańczuk M, Zatoński WA. Cigarette smoking among a sample of PONS study subjects: preliminary assessment Ann Agric Environ Med. 2011; 18(2): 215-220.
122.
Andreeva TI, Krasovsky KS. Changes in smoking prevalence in Ukraine in 2001-5. Tob Control. 2007; 16(3): 202-206.
123.
Meghea CI, Rus D, Rus IA, Summers Holtrop J, Roman L. Smoking during pregnancy and associated risk factors in a sample of Romanian women. Eur J Public Health. 2010 Dec 15. [Epub ahead of print].
125.
Office for National Statistics (ONS). The Information Centre. Statistics on smoking: England 2006. Office for National Statistics, 2006. http://www.ic.nhs.uk/pubs/ smokingeng2006/report/file.
126.
Polańska K, Hanke W, Sobala W, Jurewicz J. Exposure to tobacco smoke of pregnant women–results of prospective study in Lodz region. Przegl Lek. 2007; 64: 824-6.
127.
Johnson IL, Ashley MJ, Reynolds D, Goettler F, Lee-Han H, Stratton J, Yim C, Murray J. Prevalence of smoking associated with pregnancy in three Southern Ontario health units. Can J Public Health. 2004; 95: 209-213.
128.
Paterson JM, Neimanis IM, Bain E. Stopping smoking during pregnancy: Are we on the right track? Can J Public Health. 2003; 94: 297-299.
129.
Connor SK, McIntyre L. The sociodemographic predictors of smoking cessation among pregnant women in Canada. Can J Public Health. 1999; 90: 352-355.
130.
Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, et al. The National Birth Defects Prevention Study. Public Health Rep. 2001; 116: 32-40.
131.
Trends in smoking before, during, and after pregnancy – Pregnancy Risk Assessment Monitoring System (PRAMS). United States, 31 Sites, 2000–2005. MMWR Surveill Summ. 2009; 58: 1-29.
132.
Anderka M, Romitti PA, Sun L, Druschel C,Carmichael S, Shaw G & the National Birth Defects Prevention Study; Patterns of tobacco exposure before and during pregnancy Acta Obstetricia et Gynecologica. 2010; 89: 505-514.
133.
Tong VT, Jones JR, Dietz PM, D’Angelo D, Bombard JM. Trends in smoking before, during, and after pregnancy – pregnancy risk assessment monitoring system (PRAMS), United States, 31 sites, 2000-2005. MMWR Surveillance Summaries. 2009; 58: 1-29.
134.
Cnattingius S. The epidemiology of smoking during pregnancy: Smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine and Tobacco Research. 2004; 6: S125-40.
135.
Carmichael SL, Ahluwalia IB, and the PRAMS Working Group. Correlates of postpartum smoking relapse: results from the Pregnancy Risk Assessment Monitoring System (PRAMS). Am J Prev Med. 2000; 19: 193-6.
136.
Colman GJ, Joyce T. Trends in smoking before, during, and after pregnancy in ten states. Am J Prev Med. 2003; 24: 29-35.
137.
World Health Organization. WHO report on the global tobacco epidemic, 2009: implementing smoke-free environments. Geneva: World Health Organization, 2009.
138.
Goedhart G, Van Eijsden M, Van der Wal MF, et al. Ethnic differences in preterm birth and its subtypes: the effect of a cumulative risk profile. BJOG. 2008; 115: 710-9.
139.
Munteanu I, Trenchea M, Puscoiu C, Mihaltan F. Smoking prevalence of pregnant women in Romania: smoking effects on newborns. CHESTJ. 2007; 132: 526.
140.
Pbert L, Ockene JK, Zapka J, Ma Y, Goins KV, Oncken C, Stoddard AM. A community health center smoking cessation intervention for pregnant and postpartum women. Am J Prev Med. 2004; 26(5): 377-385.
141.
Lumley J, Oliver SS, Chamberlain C, Oakley L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2004; 4: CD001055.
142.
Office for National Statistics (National Congenital Anomaly System). Congenital anomaly statistics: notifications England and Wales 2008 (series MB3 no. 23); 2010.
143.
Russell TV, Crawford MA, Woodby LL. Measurement for active cigarette smoke exposure in prevalence and cessation studies: why simply asking pregnant women isn’t enough. Nicotine Tob Res. 2004; 6: S141-51.
144.
Markovic N, Ness RB, Cefilli D, Grisso JA, Stahmer S, Shaw LM. Substance use measures among women in early pregnancy. Am J Obstet Gynecol. 2000; 183: 627-32.
145.
Ford RP, Tappin DM, Schluter PJ, Wild CJ. Smoking during pregnancy: how reliable are maternal self reports in New Zealand? J Epidemiol Community Health. 1997; 51: 246-51.
146.
Gorber SC, Schofield-Hurwitz S, Hardt J, et al. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res. 2009; 11: 12-24.
147.
Klebanoff MA, Levine RJ, Clemens JD, DerSimonian R, Wilkins DG. Serum cotinine concentration and self-reported smoking during pregnancy. Am J Epidemiol. 1998; 148(3): 259-262.
148.
George L, Granath F, Johansson AL, Cnattingius S. Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy. Acta Obstet Gynecol Scand. 2006; 85(11): 1331-1337.
149.
Bardy AH, Seppala T, Lillsunde P, et al. Objectively measured tobacco exposure during pregnancy:neonatal effects and relation to maternal smoking. Br J Obstet Gynaecol. 1993; 100: 721-726.
150.
Chiu HT, Isaac Wu HD, Kuo HW. The relationship between self-reported tobacco exposure and cotinines in urine and blood for pregnant women. Sci Total Environ. 2008; 406(1-2): 331-6.
151.
Boyle P. Improving Health in Central and Eastern Europe. Ann Agric Environ Med. 2011; 18(2): ICID: 972488.
Share
RELATED ARTICLE
Improvement of visual identification of the journal - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher Education allocated to the activities of disseminating science.
Generation of the DOI (Digital Object Identifier) - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.